Gains of COL1A1-PDGFB genomic copies occur in fibrosarcomatous transformation of dermatofibrosarcoma protuberans
- PMID: 16980946
- DOI: 10.1038/modpathol.3800695
Gains of COL1A1-PDGFB genomic copies occur in fibrosarcomatous transformation of dermatofibrosarcoma protuberans
Abstract
Dermatofibrosarcoma protuberans is a superficial low-grade sarcoma that rarely evolves into a high-grade fibrosarcoma. Dermatofibrosarcoma protuberans is genetically characterized by the unbalanced chromosomal t(17;22)(q21;q13), usually in the form of a supernumerary ring chromosome. The product of this chromosomal translocation is the chimeric gene COL1A1-PDGFB (collagen type I alpha I-platelet-derived growth factor beta), which is amplified at low levels in the ring chromosome. The aims of this study were to evaluate (1) whether genomic gains of this fusion gene occur during the clonal evolution of dermatofibrosarcoma protuberans into fibrosarcomatous dermatofibrosarcoma protuberans and (2) whether there is a difference between the number of genomic copies of COL1A1-PDGFB between classic dermatofibrosarcoma protuberans and dermatofibrosarcoma protuberans areas associated with fibrosarcomatous dermatofibrosarcoma protuberans. Eleven cases of fibrosarcomatous dermatofibrosarcoma protuberans with both dermatofibrosarcoma protuberans and fibrosarcomatous areas and 10 cases of classic dermatofibrosarcoma protuberans were studied. Genomic copies of COL1A1-PDGFB were evaluated by fluorescence in situ hybridization using a custom designed probe for the PDGFB locus on 4 mum thick paraffin-embedded tissue sections. Genomic gains of the COL1A1-PDGFB gene were observed in six (of 10) fibrosarcomatous dermatofibrosarcoma protuberans in the fibrosarcomatous areas when compared to the dermatofibrosarcoma protuberans areas of the same tumor (2-7 gene copies (median PDGFB copy gain, 2.8) versus 1-3 gene copies (median PDGFB copy gain, 1.7), respectively, P=0.004). Four fibrosarcomatous dermatofibrosarcoma protuberans did not show genomic gains of COL1A1-PDGFB fusion gene between the two areas. Essentially no difference in the copy number of COL1A1-PDGFB fusion gene was observed between dermatofibrosarcoma protuberans areas of classic dermatofibrosarcoma protuberans and dermatofibrosarcoma protuberans areas of fibrosarcomatous dermatofibrosarcoma protuberans (median PDGFB copy gain of 1.8 versus 1.7, respectively, P=0.36). Genomic gains of COL1A1-PDGFB fusion gene is possibly an oncogenic mechanism that is identified in the clonal evolution of a subset of dermatofibrosarcoma protuberans that evolves into fibrosarcomatous dermatofibrosarcoma protuberans. Since this finding was not observed in all cases of fibrosarcomatous dermatofibrosarcoma protuberans, other oncogenic mechanisms may be operating in this form of tumor progression. Copy number of COL1A1-PDGFB fusion gene in the classic dermatofibrosarcoma protuberans areas does not seem to be a major predisposing mechanism for fibrosarcomatous transformation.
Similar articles
-
Detection of COL1A1-PDGFB fusion transcripts in dermatofibrosarcoma protuberans by reverse transcription-polymerase chain reaction using archival formalin-fixed, paraffin-embedded tissues.Diagn Mol Pathol. 1999 Sep;8(3):113-9. doi: 10.1097/00019606-199909000-00002. Diagn Mol Pathol. 1999. PMID: 10565681
-
Identification of t(17;22)(q22;q13) (COL1A1/PDGFB) in dermatofibrosarcoma protuberans by fluorescence in situ hybridization in paraffin-embedded tissue microarrays.Hum Pathol. 2011 Feb;42(2):176-84. doi: 10.1016/j.humpath.2010.07.015. Epub 2010 Dec 15. Hum Pathol. 2011. PMID: 21111450
-
Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays.Hum Pathol. 2008 Feb;39(2):184-93. doi: 10.1016/j.humpath.2007.06.009. Epub 2007 Oct 24. Hum Pathol. 2008. PMID: 17950782
-
Fibrosarcomatous Dermatofibrosarcoma Protuberans With COL1A1-PDGFB Fusion in a 2-Year-Old Child: A Rare Occurrence With Spectrum of Histopathological Findings and Review of Literature.Pediatr Dev Pathol. 2025 May-Jun;28(3):204-209. doi: 10.1177/10935266251313604. Epub 2025 Jan 21. Pediatr Dev Pathol. 2025. PMID: 39835392 Review.
-
Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment.Genes Chromosomes Cancer. 2003 May;37(1):1-19. doi: 10.1002/gcc.10202. Genes Chromosomes Cancer. 2003. PMID: 12661001 Review.
Cited by
-
DNA copy gains of tumor-related genes in vestibular schwannoma.Eur Arch Otorhinolaryngol. 2013 Sep;270(9):2433-8. doi: 10.1007/s00405-012-2269-z. Epub 2012 Nov 21. Eur Arch Otorhinolaryngol. 2013. PMID: 23179934
-
Molecular pathways and therapeutic strategies in dermatofibrosarcoma protuberans (DFSP): unravelling the tumor's genetic landscape.EXCLI J. 2024 May 14;23:727-762. doi: 10.17179/excli2024-7164. eCollection 2024. EXCLI J. 2024. PMID: 38983783 Free PMC article. Review.
-
Unforeseen clonal evolution of tumor cell population in recurrent and metastatic dermatofibrosarcoma protuberans.PLoS One. 2017 Oct 4;12(10):e0185826. doi: 10.1371/journal.pone.0185826. eCollection 2017. PLoS One. 2017. PMID: 28977029 Free PMC article.
-
Do all lung adenocarcinomas follow a stepwise progression?Lung Cancer. 2011 Oct;74(1):7-11. doi: 10.1016/j.lungcan.2011.05.021. Epub 2011 Jun 25. Lung Cancer. 2011. PMID: 21705107 Free PMC article. Review.
-
Complete resection of recurrent and initially unresectable dermatofibrosarcoma protuberans downsized by Imatinib.World J Surg Oncol. 2013 Mar 8;11:59. doi: 10.1186/1477-7819-11-59. World J Surg Oncol. 2013. PMID: 23496933 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous